Neonatal Medicine News

The American Academy of Neurology, along with the American Epilepsy Society and the Society for Maternal-Fetal Medicine, has provided a practice guidance update for women with epilepsy of childbearing potential.

The proportion of children with COVID-19-related croup increased during the period in which omicron was the predominant variant in the United States, according to a research letter published in JAMA Network Open.

Children born to mothers who used triptans for their migraines during pregnancy did not have a greater risk for ADHD symptoms or diagnosis at 5 years of age, according to a Norwegian registry-based study.

The FDA announced additional measures for making infant formula more available following prior guidance which increased importation flexibilities.

Infants born to mothers who had COVID-19 during pregnancy had differences in behavior and movement compared with infants who were unexposed to SARS-CoV-2, preliminary data presented at the European Congress of Psychiatry showed.

Regardless of disease severity, COVID-19 elicited immune responses in pregnant women, which in turn caused inflammation in the placenta, according to data published in Cell Reports.

Abbott Nutrition restarted production of infant formulas at a Michigan plant that was shut down for months after the company initiated a recall of its powder formulas, beginning the country’s ongoing formula shortage.

Zuranolone, an investigational oral drug for treating postpartum depression in women, met its primary and secondary endpoints in a phase 3 trial, Sage Therapeutics and Biogen announced in a release.

The FDA will reevaluate the safety of bisphenol A in food packaging, according to a press release from the Environmental Defense Fund.

Compared with infants born before the COVID-19 pandemic, those born during the pandemic had decreased fetal brain development, which researchers found was linked to higher levels of distress in women giving birth during the pandemic.